Traduzir "sobi also adheres" para sueco

EN “Swedish Orphan Biovitrum” for payments made by companies within Sobi Group excluding Sobi USA “Sobi, Inc.” for payments made by Sobi USA “Dova” for payments made by Dova Pharmacuticals  

• Swedish Orphan
• within Sobi Group
• Sobi USA
• Sobi
• USA
• Pharmacuticals

EN Sobi exercises an opt-in right to take over final development and commercialisation of Elocta in Sobi territories. Sobi also adds a potentially longer-acting haemophilia A candidate, rFVIIIFc-VWF-XTEN (BIVV001) to the agreement with Biogen. 

• right to take
• final development
• commercialisation of Elocta
• Sobi territories
• Sobi also adds
• potentially longer-acting haemophilia
• candidate
• rFVIIIFc-VWF-XTEN
• agreement with Biogen

EN The Sobi Code of Conduct provides a framework for what Sobi considers to be responsible and appropriate conduct. Our employees should always strive to exercise good judgment, care and consideration in their work for Sobi.

• provides a framework
• responsible
• appropriate conduct
• employees should always
• exercise good judgment
• care

EN Sobi also adheres to local spend transparency codes and legislation in Belgium, Denmark, Estonia, France, Greece, Latvia, Lithuania, Netherlands, Portugal, Romania, Saudi Arabia, Slovakia and Turkey. 

• Sobi also adheres
• local spend transparency
• legislation in Belgium
• Denmark
• Estonia
• France
• Greece
• Latvia
• Lithuania
• Netherlands
• Portugal
• Romania
• Saudi Arabia
• Slovakia
• Turkey

EN To find out more, please contact the Sobi Corporate Development Team at bd@sobi.com.

• Sobi Corporate Development

EN The Sobi share (STO:SOBI) is listed in the Large Cap segment at Nasdaq Stockholm.

• Sobi share

EN Swedish Orphan Biovitrum AB (publ) (”Sobi”) is a Swedish public limited liability company. The Board of Directors shall have its registered office in Stockholm. Sobi is listed on Nasdaq Stockholm.

• Swedish Orphan Biovitrum
• publ
• Swedish public limited
• company
• Board of Directors
• Sobi is listed
• Nasdaq

EN Sobi acquires emapalumab and related assets, giving Sobi access to world-class R&D capabilities in the Immunology field. 

• Sobi acquires emapalumab
• related assets
• giving Sobi access
• world-class
• Immunology field

EN If you have concerns or questions about possible ethical misconduct concerning Sobi, you may report this to the Sobi Compliance Hotline.

• concerns
• questions about possible
• misconduct concerning Sobi
• Sobi Compliance

EN If you have any questions about the payments disclosed by Sobi please use the e-mail address info@sobi.com. In order for us to be able to quickly respond please state “Transparency” in the subject field.

• disclosed by Sobi
• e-mail address
• able to quickly
• state
• subject

EN At this time, all Sobi’s contract and manufacturing sites and logistics partners are up and running and continue the uninterrupted supply of Sobi products.

• contract
• manufacturing sites
• running
• continue the uninterrupted
• Sobi

EN In December 2019 a team from Sobi visited Kenya with the WFH to see for themselves the impact of Sobi’s donation on the lives of patients in all social classes in Kenya

• December a team
• Sobi visited Kenya
• themselves the impact
• classes in Kenya

EN ExpressVPN was also independently audited by PwC, with the results showing that ExpressVPN strictly adheres to its privacy policy and commitment to anonymity.

• audited by PwC
• privacy policy

EN After they observed those operations, interviewed employees, and inspected NordVPN?s servers and databases, auditors verified that NordVPN strictly adheres to its no-logs policy

• After they observed
• operations
• interviewed employees
• inspected NordVPN
• servers
• databases
• no-logs policy

EN Avira adheres to GDPR and the German Telemedia Act

• German Telemedia Act

EN LanguageWire adheres to international security standards and quality management best practices.

• security standards

EN OtterBox adheres to a strict privacy policy. We do not share, lend, sell or otherwise disclose our subscriber?s names. Cannot be combined with any other promotion.

• strict privacy policy
• share
• lend
• sell
• names
• Cannot be combined

EN Planview PPM Pro Cloud PPM solutions are globally hosted in Amazon’s EC2 cloud platform, and our Cloud Platform adheres to SaaS best practices to ensure secure, reliable, and smooth operations.

• Planview PPM Pro
• cloud platform
• Cloud Platform adheres
• SaaS best practices
• ensure secure
• reliable
• smooth

EN Planview adheres to stringent standards and regulations and undergoes independent validation of compliance.

• standards
• regulations
• undergoes independent validation

EN Xolphin has the right to conduct (or have conducted) an audit at the location of the Reseller in order to verify that the Reseller adheres to the rules under the Agreement.

• conduct
• conducted
• Reseller in order

EN Whilst Google remains globally focussed, Baidu is focussed on the Chinese market, and adheres to all of the local regulations and censorship laws.

• Whilst Google remains
• focussed
• Baidu is focussed
• Chinese market
• local regulations
• censorship

EN Planview adheres to stringent standards and regulations and undergoes independent validation of compliance.

• standards
• regulations
• undergoes independent validation

EN Planview PPM Pro Cloud PPM solutions are globally hosted in Amazon’s EC2 cloud platform, and our Cloud Platform adheres to SaaS best practices to ensure secure, reliable, and smooth operations.

• Planview PPM Pro
• cloud platform
• Cloud Platform adheres
• SaaS best practices
• ensure secure
• reliable
• smooth

EN Pinterest adheres to the Digital Advertising Alliance’s Self-Regulatory Principles for Online Behavioral Advertising and provides an opt-out on the DAA’s consumer choice tool at optout.aboutads.info

• Digital Advertising
• Behavioral Advertising
• provides an opt-out
• consumer choice tool

EN Links to other Sobi sites and public platforms are also accessible.

• sites

EN Click on the table below to view Sobi’s disclosure reports under the EFPIA code. The methodological notes give further explanation of what we are disclosing. Links to public platforms are also accessible. 

• below to view
• disclosure reports under
• EFPIA code
• methodological notes give
• disclosing
• Links to public
• accessible

EN At Sobi, we also see the importance of sharing understanding and experiences of Still’s disease

• Sobi
• importance of sharing
• disease

EN At Sobi, we are transforming life for people with rare diseases. As an international biopharmaceutical company, we provide access to innovative treatments in the areas of haematology, immunology and specialty care.

• Sobi
• rare diseases
• international biopharmaceutical company
• access to innovative
• areas of haematology
• immunology
• specialty

EN The field of immunology has long been at the heart of what we do at Sobi, allowing us to gain extensive experience over many years

• field of immunology
• Sobi
• years

EN Sobi's key contribution to sustainable development and our overall sustainability objective – to transform the lives of people living with rare diseases – is closely aligned with our vision and our operations.

• Sobi's key contribution
• sustainable development
• overall sustainability objective
• transform the lives
• living with rare
• vision

EN Sobi is a signatory to the UN Global Compact, and we have integrated the ten principles of the Global Compact into our core business operations

• UN Global Compact
• integrated the ten
• core business operations

EN The field of immunology has long been at the heart of what we do at Sobi, allowing us to gain extensive experience over many years.

• field of immunology
• Sobi

EN Sobi has supported the World Federation of Hemophilia Humanitarian Aid Program since 2014.

• Sobi has supported
• Federation of Hemophilia
• Aid Program since

EN *Call options issued by Investor AB entitling to purchase Sobi shares.

• Sobi

EN * This medicinal product is subject to additional monitoring. Applicable to one or several markets.**Sobi and Sanofi collaborate on the development and commercialisation of Alprolix and Elocta/Eloctate.

• additional monitoring
• several
• development
• commercialisation of Alprolix
• Elocta

EN The primary purpose of the committee is to oversee Sobi's accounting and financial reporting processes and the audits of the financial statements.

• Sobi's accounting
• financial reporting processes

EN Sobi complies with the Corporate Governance Code without any deviations. 

• Corporate Governance Code
• deviations

EN The Corporate Governance Report describes Sobi’s corporate governance activities during the recent financial year. The Corporate Governance Reports for the past ten years are available further down on this page. 

• Corporate Governance Report
• corporate governance activities
• recent financial year
• Corporate Governance Reports
• past ten years
• available further down
• page

EN Sobi’s highest decision-making body is the General Meeting through which shareholders have the right to make decisions on the company’s affairs

• highest decision-making body
• affairs

EN The Nomination Committee represents Sobi’s shareholders and is tasked with preparing the AGM’s resolutions on election and remuneration matters

• Nomination Committee represents
• shareholders
• tasked with preparing
• resolutions on election
• remuneration matters

EN We aim to have a strong correlation between Sobi’s compensation elements, the long-term strategy and sustainability

• strong correlation between
• compensation elements
• long-term strategy
• sustainability

EN The Board of Directors has overall responsibility for Sobi’s sustainability performance, which is publicly reported each year in the Annual and Sustainability Report

• Board of Directors
• sustainability performance
• publicly reported each
• Annual
• Sustainability Report

EN The President and CEO and the Executive Committee approve Sobi’s sustainability strategy, ensure compliance, and decide on overall objectives and implementation of the sustainability strategy.

• President
• CEO
• Executive Committee approve
• sustainability strategy
• ensure compliance
• decide on overall

EN For more information about the Company’s long-term share-related incentive plans, including the criteria which the outcome depends on, please see www.sobi.com.

• long-term share-related incentive

EN Research & development | Sobi

• Research
• developmentxSobi

EN Sobi’s strengthens focus in late-stage R&D in Haematology and Immunology and discontinues discovery/early research outside core areas.

• D in Haematology
• Immunology
• discontinues discovery
• early research outside

EN Sobi acquires Dova Pharmaceuticals creating a global growth platform in haematology

• Sobi acquires Dova
• creating a global
• platform in haematology

EN The provides Sobi with Doptelet, a second-generation small-molecule thrombopotein receptor (TPO) agonist used in the treatment of thrombocytopenia by increasing platelet count.

• second-generation small-molecule thrombopotein
• TPO
• treatment of thrombocytopenia
• increasing platelet

EN Sobi enters into an expanded agreement with Sanofi to exercise early opt-in for the development and  commercialisation of BIVV001, an investigational extended half-life factor VIII therapy.

• exercise early opt-in
• development
• investigational extended half-life
• VIII

EN Sobi acquires US rights to Synagis, indicated for the prevention of serious lower respiratory tract infection caused by respiratory syncytial virus (RSV) in infants and young children at high risk of RSV disease, from AstraZeneca.

• Sobi acquires US
• Synagis
• serious lower respiratory
• syncytial virus
• RSV
• infants
• risk of RSV